The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Business Unit - Falanx Cyber Technologies

13 Feb 2017 07:00

RNS Number : 6698W
Falanx Group Limited
13 February 2017
 

Falanx Group Limited

("Falanx" or "the Company")

 

NEW BUSINESS UNIT - FALANX CYBER TECHNOLOGIES

 

Falanx Group (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to announce the establishment of Falanx Cyber Technologies.

 

Falanx Cyber Technologies

 

Our newly formed business unit has been created in order to gain significant commercial advantage from the management of advanced cyber threats we see every day. Falanx Cyber Technologies uses knowledge gained in Falanx Cyber Defence, our managed service business, to develop and produce a range of proprietary technology to continuously improve our 'Security-as-a-Service' offering. We also distribute through channel partners to the wider SME and Major Enterprise market.

 

The technology development hub led by Jay Abbott, Executive Director: Cyber Defence, is now fully established in our new Cyber Defence Centre in Birmingham. New technology is rapidly prototyped as a consequence of the intelligence generated by our Assessment, Monitor and Response teams. These new technologies are deployed as part of our managed service and productized for distribution through our channel partnerships. This form of rapid technology development, based on real-time operations, carries an extremely low cost and we therefore remain on track to achieve profitability and positive cash flow next financial year

 

Falanx Cyber Technologies is focused on the creation of flexible, scalable and cost-effective technology for both the SME market and major enterprises who require an outsourced solution. As a result, Falanx Group is set to develop into a fully integrated cyber technology and managed services operator, maintaining the ability to sell our own continuously improving technology and services, more flexibly and at a higher margin of sale.

 

 

Jay Abbott, Executive Director: Cyber Defence, commented:

 

"The development of our own technology is a direct result of working alongside our clients and dealing with real-world issues, not isolated in a software laboratory. We therefore see the latest threats as they emerge and create real, effective, solutions which advance our technology and benefit all of our clients and partners."

 

Stuart Bladen, Chief Executive Officer of Falanx Group, commented:

 

"The creation and ownership of our own security technology is fundamental to our business. It provides us with the ability to be more agile, adaptive and efficient than our competitors, who in the main, re-sell or license their tool-set. The retention of this Intellectual Property and therefor increased margin of sale lead to greater shareholder value."

 

 

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive Officer

 

 

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

 

+44 (0) 203 368 3551

 

Whitman Howard Limited

Broker

Nick Lovering / Francis North

 

+44 (0) 207 659 1234

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKLLFFDLFZBBX
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.